| Pharmaceutical Information |
| Drug Name |
Optimark |
| Drug ID |
BADD_D01621 |
| Description |
Gadoversetamide, marketed under the trade name OptiMARK, is a gadolinium compound used as a contrast agent in magnetic resonance imaging (MRI), particularly imaging of the brain, spine and liver. |
| Indications and Usage |
Gadoversetamide is an MRI contrast agent used for MRI diagnostic procedures to provide increased enhancement and visualization of lesions of the brain, spine and liver, including tumors. |
| Marketing Status |
Prescription |
| ATC Code |
V08CA06 |
| DrugBank ID |
DB00538
|
| KEGG ID |
D01646
|
| MeSH ID |
C112666
|
| PubChem ID |
6435809
|
| TTD Drug ID |
D0X0GI
|
| NDC Product Code |
Not Available |
| Synonyms |
gadoversetamide | OptiMARK |
|
| Chemical Information |
| Molecular Formula |
C20H34GdN5O10 |
| CAS Registry Number |
131069-91-5 |
| SMILES |
COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3] |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
